Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The Relationship Between Genetic Variants at Loci 9p21, 6q25.1, and 2q36.3 and the Development of Cardiac Allograft Vasculopathy in Heart Transplant Patients

D. Dlouha, K. Janouskova, J. Vymetalova, S. Novakova, S. Chytilova, M. Lukasova, JA. Hubacek

. 2025 ; 16 (2) : . [pub] 20250219

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25009845

Grant support
NU20-06-00061 Ministry of Health of the Czech Republic
IN 00023001 Ministry of Health of the Czech Republic

BACKGROUND: Cardiac allograft vasculopathy (CAV) is an accelerated form of coronary artery disease (CAD) that is characterized by concentric fibrous intimal hyperplasia along the length of coronary vessels, and is recognized as long-term complication after heart transplantation. The chromosomal loci 9p21, 6q25.1, and 2q36.3, represented by their respective leading variants rs10757274, rs6922269 and rs2943634, have been linked with a history of CAD by genome-wide association studies. We aimed to investigate the associations of genetic variants at the loci 9p21, 6q25.1, and 2q36.3 with CAV as genetic risk factors for early prediction. METHODS: Genomic DNA was extracted from paired aortic samples of 727 heart recipients (average age 50.8 ± 12.2 years; 21.3% women) and corresponding donors (average age 39.7 ± 12.0 years; 26.1% women). The variants within the loci 9p21, 6q25.1, and 2q36.3 were genotyped using PCR-RFLP. RESULTS: The recipients' variants of 9p21 (OR 1.97; 95% CI, 1.21-3.19 for GG vs. +A comparison, p = 0.0056) and 2q36.3 (OR 2.46; 95% CI, 1.12-6.17 for +C vs. AA comparison, p = 0.0186) were associated with higher incidence of CAV during the first year following heart transplantation. No such association was found for donor genotypes. CONCLUSIONS: Our data suggest that variants at the locus 9p21 (rs10757274) and 2q36.3 (rs2943634) are associated with early CAV development.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009845
003      
CZ-PrNML
005      
20250429135159.0
007      
ta
008      
250415s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/genes16020236 $2 doi
035    __
$a (PubMed)40004565
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dlouha, Dana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000171671336
245    14
$a The Relationship Between Genetic Variants at Loci 9p21, 6q25.1, and 2q36.3 and the Development of Cardiac Allograft Vasculopathy in Heart Transplant Patients / $c D. Dlouha, K. Janouskova, J. Vymetalova, S. Novakova, S. Chytilova, M. Lukasova, JA. Hubacek
520    9_
$a BACKGROUND: Cardiac allograft vasculopathy (CAV) is an accelerated form of coronary artery disease (CAD) that is characterized by concentric fibrous intimal hyperplasia along the length of coronary vessels, and is recognized as long-term complication after heart transplantation. The chromosomal loci 9p21, 6q25.1, and 2q36.3, represented by their respective leading variants rs10757274, rs6922269 and rs2943634, have been linked with a history of CAD by genome-wide association studies. We aimed to investigate the associations of genetic variants at the loci 9p21, 6q25.1, and 2q36.3 with CAV as genetic risk factors for early prediction. METHODS: Genomic DNA was extracted from paired aortic samples of 727 heart recipients (average age 50.8 ± 12.2 years; 21.3% women) and corresponding donors (average age 39.7 ± 12.0 years; 26.1% women). The variants within the loci 9p21, 6q25.1, and 2q36.3 were genotyped using PCR-RFLP. RESULTS: The recipients' variants of 9p21 (OR 1.97; 95% CI, 1.21-3.19 for GG vs. +A comparison, p = 0.0056) and 2q36.3 (OR 2.46; 95% CI, 1.12-6.17 for +C vs. AA comparison, p = 0.0186) were associated with higher incidence of CAV during the first year following heart transplantation. No such association was found for donor genotypes. CONCLUSIONS: Our data suggest that variants at the locus 9p21 (rs10757274) and 2q36.3 (rs2943634) are associated with early CAV development.
650    _2
$a lidé $7 D006801
650    12
$a transplantace srdce $x škodlivé účinky $7 D016027
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dospělí $7 D000328
650    12
$a alografty $7 D064591
650    12
$a nemoci koronárních tepen $x genetika $x patologie $x etiologie $7 D003324
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a lidské chromozomy, pár 9 $x genetika $7 D002899
650    _2
$a lidské chromozomy, pár 6 $x genetika $7 D002896
650    _2
$a lidské chromozomy, pár 2 $x genetika $7 D002889
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a celogenomová asociační studie $7 D055106
655    _2
$a časopisecké články $7 D016428
700    1_
$a Janouskova, Kristyna $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0009000962311182
700    1_
$a Vymetalova, Jevgenija $u Cardio Center, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Novakova, Sarka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Chytilova, Sarka $u Statistical Unit, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000339565968
700    1_
$a Lukasova, Marianna $u Cardio Center, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
700    1_
$a Hubacek, Jaroslav A $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, 11636 Prague, Czech Republic $1 https://orcid.org/0000000165371353
773    0_
$w MED00174652 $t Genes $x 2073-4425 $g Roč. 16, č. 2 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40004565 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135154 $b ABA008
999    __
$a ok $b bmc $g 2311310 $s 1246926
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 16 $c 2 $e 20250219 $i 2073-4425 $m Genes $n Genes (Basel) $x MED00174652
GRA    __
$a NU20-06-00061 $p Ministry of Health of the Czech Republic
GRA    __
$a IN 00023001 $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options